Bartl M - Search Results

1

Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease.

Bartl M, Dakna M, Schade S, Otte B, Wicke T, Lang E, Starke M, Ebentheuer J, Weber S, Toischer K, Schnelle M, Sixel-Döring F, Trenkwalder C, Mollenhauer B. Bartl M, et al. Mov Disord. 2023 Jan;38(1):68-81. doi: 10.1002/mds.29257. Epub 2022 Oct 20. Mov Disord. 2023. PMID: 36267007

2

[Frequent neurological diseases associated with the restless legs syndrome].

Bartl M, Winkelmann J, Högl B, Paulus W, Trenkwalder C. Bartl M, et al. Nervenarzt. 2018 Oct;89(10):1156-1164. doi: 10.1007/s00115-018-0528-y. Nervenarzt. 2018. PMID: 29736677 German.

3

I_h contributes to increased motoneuron excitability in restless legs syndrome.

Czesnik D, Howells J, Bartl M, Veiz E, Ketzler R, Kemmet O, Walters AS, Trenkwalder C, Burke D, Paulus W. Czesnik D, et al. Among authors: bartl m. J Physiol. 2019 Jan;597(2):599-609. doi: 10.1113/JP275341. Epub 2018 Nov 24. J Physiol. 2019. PMID: 30430565 Free PMC article.

4

[Update on restless legs syndrome].

Bartl M, Trenkwalder C, Muntean ML, Sixel-Döring FRK. Bartl M, et al. Nervenarzt. 2020 Oct;91(10):955-966. doi: 10.1007/s00115-020-00997-8. Nervenarzt. 2020. PMID: 32930812 German.

5

[Intravenous iron supplementation therapy Restless-Legs-Syndrome].

Bartl M, Trenkwalder C, Muntean ML, Sixel-Döring F. Bartl M, et al. Nervenarzt. 2021 Oct;92(10):1067. doi: 10.1007/s00115-021-01096-y. Epub 2021 Mar 9. Nervenarzt. 2021. PMID: 33751129 German. No abstract available.

6

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B. Schulz I, et al. Among authors: bartl m. Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 7. Mov Disord. 2021. PMID: 34363416

7

Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.

Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B; Parkinson’s Progression Markers Initiative. Bartl M, et al. PLoS One. 2021 Oct 7;16(10):e0257372. doi: 10.1371/journal.pone.0257372. eCollection 2021. PLoS One. 2021. PMID: 34618817 Free PMC article. Clinical Trial.

8

Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease.

Bartl M, Dakna M, Schade S, Wicke T, Lang E, Ebentheuer J, Weber S, Trenkwalder C, Mollenhauer B. Bartl M, et al. J Parkinsons Dis. 2022;12(1):437-452. doi: 10.3233/JPD-212860. J Parkinsons Dis. 2022. PMID: 34719511

9

Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.

Bartl M, Xylaki M, Bähr M, Weber S, Trenkwalder C, Mollenhauer B. Bartl M, et al. Neurobiol Dis. 2022 Aug;170:105744. doi: 10.1016/j.nbd.2022.105744. Epub 2022 May 2. Neurobiol Dis. 2022. PMID: 35513230 Free article. Review.

10

Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up.

Abdi IY, Bartl M, Dakna M, Abdesselem H, Majbour N, Trenkwalder C, El-Agnaf O, Mollenhauer B. Abdi IY, et al. Among authors: bartl m. Neurobiol Dis. 2023 Feb;177:105997. doi: 10.1016/j.nbd.2023.105997. Epub 2023 Jan 10. Neurobiol Dis. 2023. PMID: 36634823 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page